Ma, W., Zhang, B., & Chen, X. (2025). Glucagon‐like pepetide‐1 receptor agonist suggests novel therapeutic options for hypothalamic obesity. Journal of Diabetes Investigation, 16(3), 357. https://doi.org/10.1111/jdi.14372
Chicago-referens (17:e uppl.)Ma, Wanlu, Bo Zhang, och Xiaoping Chen. "Glucagon‐like Pepetide‐1 Receptor Agonist Suggests Novel Therapeutic Options for Hypothalamic Obesity." Journal of Diabetes Investigation 16, no. 3 (2025): 357. https://doi.org/10.1111/jdi.14372.
MLA-referens (9:e uppl.)Ma, Wanlu, et al. "Glucagon‐like Pepetide‐1 Receptor Agonist Suggests Novel Therapeutic Options for Hypothalamic Obesity." Journal of Diabetes Investigation, vol. 16, no. 3, 2025, p. 357, https://doi.org/10.1111/jdi.14372.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
